Fortress Biotech, Inc. - Mar 31, 2025 Form SCHEDULE 13D/A Schedule Report for Avenue Therapeutics, Inc. (ATXI)

Filing Manager: Fortress Biotech, Inc.
Reporting Manager: Fortress Biotech, Inc.
Security: Avenue Therapeutics, Inc. Common Stock, $0.0001 Par Value
Symbol: ATXI
Shares outstanding: 3.19M shares
Disclosed Ownership: 329K shares
Ownership: 10.3%
Form type: SCHEDULE 13D/A
Date filed: 4/2/2025, 05:00 PM
Date of event: Mar 31, 2025
Previous filing: Jan 3, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Fortress Biotech, Inc.	10.3%	329K	329K	0	/s/ Lindsay A. Rosenwald	Lindsay A. Rosenwald, M.D. / Chairman, President and Chief Executive Officer	0001429260